Inventor

Zhe Nie

Inventor

San Diego, CA, US

Overview

2009–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 41 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds39%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

A61KPreparations for medical, dental or toiletry purposes24%

PatentTitleYear

10,870,634Histone demethylase inhibitors2020 10,807,956Histone demethylase inhibitors2020 10,654,830Histone demethylase inhibitors2020 10,626,103Inhibitor of lysine specific demethylase-12020 10,626,104Inhibitors of lysine specific demethylase-12020 10,597,365Histone demethylase inhibitors2020 10,414,750Inhibitors of lysine specific demethylase-12019 10,273,222Histone demethylase inhibitors2019 10,179,769Histone demethylase inhibitors2019 10,174,003Histone demethylase inhibitors2019 10,173,996Histone demethylase inhibitors2019 10,150,754Histone demethylase inhibitors2018 10,100,046Inhibitors of lysine specific demethylase-12018 10,071,984Histone demethylase inhibitors2018 9,963,441Histone demethylase inhibitors2018 9,908,865'Histone demethylase inhibitors'2018 9,902,719'Inhibitors of lysine specific demethylase-1'2018 9,896,436'Histone demethylase inhibitors'2018 9,828,343Histone demethylase inhibitors2017 9,725,441'Histone demethylase inhibitors'2017 9,714,230'Histone demethylase inhibitors'2017 9,701,657'Histone demethylase inhibitors'2017 9,676,770'Histone demethylase inhibitors'2017 9,663,514'Substituted 6-aza-isoindolin-1-one derivatives'2017 9,611,221'Histone demethylase inhibitors'2017 9,604,961'Histone demethylase inhibitors'2017 9,527,829'Histone demethylase inhibitors'2016 9,458,129'Histone demethylase inhibitors'2016 9,447,045'Histone demethylase inhibitors'2016 9,181,255'Fused heteroaromatic pyrrolidinones as SYK inhibitors'2015 9,133,166'Histone demethylase inhibitors'2015 9,107,916'Histone demethylase inhibitors'2015 9,108,970'Fused heteroaromatic pyrrolidinones'2015 9,085,534'Histone demethylase inhibitors'2015 9,056,873'Substituted 6-aza-isoindolin-1-one derivatives'2015 8,987,461'Histone demethylase inhibitors'2015 8,952,151'Histone demethylase inhibitors'2015 8,440,689'Fused heteroaromatic pyrrolidinones'2013 8,318,727'Polo-like kinase inhibitors'2012 8,202,990'Polo-like kinase inhibitors'2012 7,517,882'Protein kinase inhibitors'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2020Based in San Diego, CA, US· patent location history

2012–2015Patents assigned to TAKEDA PHARMACEUTICAL (6)· patent assignee history

2012–2015Patents assigned to NIE ZHE (5)· patent assignee history

2012–2015Patents assigned to FEHER VICTORIA (3)· patent assignee history

2013Based in San Bernardino, CA, US· patent location history

2015–2017Patents assigned to QUANTICEL PHARMACEUTICALS INC (9)· patent assignee history

2016–2020Patents assigned to CELGENE QUANTICEL RES INC (28)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CELGENE QUANTICEL RES INC	28	2016–2020
QUANTICEL PHARMACEUTICALS INC	9	2015–2017
TAKEDA PHARMACEUTICAL	6	2012–2015
NIE ZHEself	5	2012–2015
FEHER VICTORIA	3	2012–2015

Locations

Location	Patents	Span
San Diego, California, US	40	2009–2020
San Bernardino, California, US	1	2013